Hairong Zhou

发表

Tyrosine Kinase Inhibitors. Part 5. Synthesis and Structure‐Activity Relationships for 4‐((Phenylmethyl)amino)‐ and 4‐(Phenylamino) quinazolines as Potent Adenosine 5′‐Triphosphate Binding Site Inhibitors of the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor.

W. Denny, G. Rewcastle, A. Bridges, 1995 .

Tyrosine Kinase Inhibitors. Part 10. Isomeric 4‐((3‐Bromophenyl)amino) pyrido(d)pyrimidines are Potent ATP Binding Site Inhibitors of the Tyrosine Kinase Function of the Epidermal Growth Factor Receptor (EGFR) .

W. Denny, G. Rewcastle, A. Bridges, 1996 .

Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.

D. W. Fry, D. Mcnamara, Hairong Zhou, 2005, Journal of medicinal chemistry.

Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors.

P. Ellis, W. Denny, A. Bridges, 2006, Journal of medicinal chemistry.

Apatinib in gastric carcinoma: A case report of partial response for first‐line treatment in advanced disease

Hairong Zhou, Yaping Wang, Haoran Zhang, 2017, Asia-Pacific journal of clinical oncology.

Regulatory effects of lncRNA ATB targeting miR‐200c on proliferation and apoptosis of colorectal cancer cells

Hairong Zhou, Yaping Wang, Juan Chen, 2020, Journal of cellular biochemistry.

Synthesis of [1]benzothieno[3,2-d]pyrimidines substituted with electron donating substituents on the benzene ring

A. Bridges, Hairong Zhou, 1997 .

Synthesis and characterization of lanthanide amides bearing phenoxy(quinolinyl)amide ligand and their application in the ring-opening polymerization of 1,4-dioxan-2-one

Hairong Zhou, Yingming Yao, Bing Wu, 2014 .

Synthesis of [1]Benzothieno[3,2‐d]pyrimidines Substituted with Electron‐Donating Substituents on the Benzene Ring.

Hairong Zhou, A. Bridges, 1998 .

Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARalpha/gamma dual agonists, and X-ray crystallographic studies.

Hairong Zhou, J. Ohren, L. Royer, 2008, Bioorganic & medicinal chemistry.

Dietary intake of fructose increases purine de novo synthesis: A crucial mechanism for hyperuricemia

Hairong Zhou, Xing Wei, Yajing Li, 2022, Frontiers in Nutrition.

Effect of inhibiting ACAT-1 expression on the growth and metastasis of Lewis lung carcinoma

Hairong Zhou, Jianguo Hu, Jingru Yang, 2019, Oncology letters.

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review

Hairong Zhou, Jingru Yang, Yaping Wang, 2018, OncoTargets and therapy.

Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts

A. Bridges, D. W. Fry, W. Elliott, 2000, Cancer Chemotherapy and Pharmacology.

The expression and the role of PIWI like RNA-mediated gene silencing 3 (PIWIL3) in lung cell line

Hairong Zhou, M. Bi, Z. Gao, 2020, Translational cancer research.

Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]ĭndoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.

A. Bridges, D. W. Fry, H. D. Showalter, 1999, Journal of medicinal chemistry.